Article
Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.
PloS one - 1 Jan 2018
Heraudeau Adeline, Delluc Aurélien, Le Henaff Mickaël, Lacut Karine, Leroyer Christophe, Desrues Benoit, Couturaud Francis, Tromeur Cécile
Abstract excerpt
BACKGROUND: Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation. The impact of the factor V Leiden on the risk of VTE in cancer patients remains uncertain. OBJECTIVE: To assess the impact of factor V Leiden mutation in cancer-associated thrombosis. METHODS: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.